Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Dalteparin sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 29,094Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as:
    Molecular Formula
    C12H17NO20S3-4
    Molecular Weight
    591.5  g/mol
    InChI Key
    OHJKXVLJWUPWQG-IUYNYSEKSA-J
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4S,6R)-6-[(2R,4R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate
    2.1.2 InChI
    InChI=1S/C12H21NO20S3/c14-4-3(13-34(20,21)22)11(19)30-2(1-29-35(23,24)25)7(4)31-12-9(33-36(26,27)28)6(16)5(15)8(32-12)10(17)18/h2-9,11-16,19H,1H2,(H,17,18)(H,20,21,22)(H,23,24,25)(H,26,27,28)/p-4/t2-,3?,4-,5?,6+,7?,8?,9?,11?,12-/m1/s1
    2.1.3 InChI Key
    OHJKXVLJWUPWQG-IUYNYSEKSA-J
    2.1.4 Canonical SMILES
    C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-]
    2.1.5 Isomeric SMILES
    C([C@@H]1C([C@@H](C(C(O1)O)NS(=O)(=O)[O-])O)O[C@H]2C([C@H](C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-]
    2.2 Create Date
    2009-05-14
    3 Chemical and Physical Properties
    Molecular Weight 591.5 g/mol
    Molecular Formula C12H17NO20S3-4
    XLogP3-5.6
    Hydrogen Bond Donor Count5
    Hydrogen Bond Acceptor Count21
    Rotatable Bond Count6
    Exact Mass590.95060545 g/mol
    Monoisotopic Mass590.95060545 g/mol
    Topological Polar Surface Area376 Ų
    Heavy Atom Count36
    Formal Charge-4
    Complexity1040
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count6
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameHeparin sodium in plastic container
    Active IngredientHeparin sodium
    Dosage FormInjectable
    RouteInjection
    Strength10,000 units/ml; 5,000 units/ml; 20,000 units/ml; 1,000 units/ml
    Market StatusPrescription
    CompanyFresenius Kabi Usa

    2 of 4  
    Drug NameHeparin sodium preservative free
    Active IngredientHeparin sodium
    Dosage FormInjectable
    RouteInjection
    Strength10,000 units/ml; 1,000 units/ml
    Market StatusPrescription
    CompanyHospira; Shenzhen Techdow; Pfizer; Fresenius Kabi Usa; Sagent Pharms

    3 of 4  
    Drug NameHeparin sodium in plastic container
    Active IngredientHeparin sodium
    Dosage FormInjectable
    RouteInjection
    Strength10,000 units/ml; 5,000 units/ml; 20,000 units/ml; 1,000 units/ml
    Market StatusPrescription
    CompanyFresenius Kabi Usa

    4 of 4  
    Drug NameHeparin sodium preservative free
    Active IngredientHeparin sodium
    Dosage FormInjectable
    RouteInjection
    Strength10,000 units/ml; 1,000 units/ml
    Market StatusPrescription
    CompanyHospira; Shenzhen Techdow; Pfizer; Fresenius Kabi Usa; Sagent Pharms